{"name":"Abdera Therapeutics Inc.","slug":"abdera-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"225Ac-ABD147","genericName":"225Ac-ABD147","slug":"225ac-abd147","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"225Ac-ABD147","genericName":"225Ac-ABD147","slug":"225ac-abd147","phase":"phase_1","mechanism":"Alpha-particle emitting radiopharmaceutical that delivers targeted radiation to cancer cells.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxPOVBpRnNkZGlWSnJoS05EX19KbDRCTG90dG01MmI0eTIwQ3ZZNldjZGdCY3gtT2RVZHc0MVY2R25WVzYyakdHaE5XQ2hYN2lSVV91ZzVvWHEwTThCUkVlemxyRjBoS242VDd5TnltWTZ5MmFoZlJZVDhPTUg1dFhWZWlPLXdLOXFtSlphNjEwUDhPZklmdnBHcVhadGQ1QzMwMFlCTFpsY0dzaEd1MDlnclI5djFRMXdRZWlpb244N00ydVFId1h3dXNTb2ZoLWlMQVNFbDFaZHJGakF0T0dhQUZoZlBrYXg4MWpxY2hsSGlYZVYt?oc=5","date":"2025-12-18","type":"pipeline","source":"businesswire.com","summary":"Abdera Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 - businesswire.com","headline":"Abdera Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOU1JOTV9fRk80U3dfQUdRRF9nb1lvTzdaMWRXaE9FOFExbnUxYXFXc01rblg3QUVvbXI5RlpSR2RTYXpsb0t2WlpBVE9PSFpEOUtrWHFxcmRpQXZncElacHd2bXNHZkkyeVVNVE5nU2JfM3FyUEVKYXFwd1I0VTBxeGd6Q0VmR1RtUGIyNkQ4a2FrdThOdG9ZVmY3bmhwUQ?oc=5","date":"2025-08-12","type":"pipeline","source":"The Healthcare Technology Report.","summary":"The Top 25 Biotech and Life Sciences Companies of 2025 - The Healthcare Technology Report.","headline":"The Top 25 Biotech and Life Sciences Companies of 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxORm9GSU1VQWs0cWJRLUJYLXEtUE5aZFpLUklwZU9aUEJPS3pLRU84dW5ZMldTbG5rRElTbXljUVdrVEExSWQ5Uk1jRU5HRTc2UmJZY3UzZmp6bXlpcW9CTjJJVmNOU0NoMnJ5RlR3ZVExdU9ydTVidm05Y3FZQ2hxOWVvTXNKQ1lhd3REaElmMGhOVUhET2p2ckdXLW03Mk5vQUV6V2EwVnZzSld1MEdFajFYRExmOVZ6Y0gyMjZ4M1VfYzMxbGpZdnJVV3pGUQ?oc=5","date":"2025-07-08","type":"pipeline","source":"businesswire.com","summary":"Abdera Therapeutics Appoints Rachael Brake, Ph.D., as Chief Scientific Officer - businesswire.com","headline":"Abdera Therapeutics Appoints Rachael Brake, Ph.D., as Chief Scientific Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNVEpaWXFNSHhONVJYc3NYZXJxZUt6TWVGa2FyLTExRGh4TlVtSnRLX2pyNi1ZYk5BUGg1TnRaMkc0MlZUaldjaTVSYjBQa2ZvSk9fQ2FuQUtYSERPMUltdUloRHBNa2toRmJEMUdHRVdKUWNFcWhMZE9IRGpxYXc4S1p3VXB6cXZfUXRKTmlocG5jQQ?oc=5","date":"2024-08-05","type":"pipeline","source":"fiercebiotech.com","summary":"Introducing Fierce Biotech's 2024 Fierce 15 - fiercebiotech.com","headline":"Introducing Fierce Biotech's 2024 Fierce 15","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-06-27","type":"regulatory","source":"businesswire.com","summary":"Abdera Therapeutics Announces FDA Fast Track Designation for ABD-147, a Next-Generation Precision Radiopharmaceutical Therapy, for the Treatment of Patients with Extensive-stage Small Cell Lung Cancer","headline":"Abdera Therapeutics Announces FDA Fast Track Designation for ABD-147, a Next-Generation Precision Radiopharmaceutical Th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNQ0FfZng1Nk5SSHdnbDlpMnkzamJZOE9oRDRTa3pZdG5xd3cxU3M4ZEhzUGNmcVVaTXpwT2V5RTY3c1pYNDV2Q3JSdzVIRlFNVWk4TXBUVjRBV0pRWlBuVllQTGtaY2lMdTIyN1RvVS1jTDZzLUlFNDBIbXYwcEZVSHN6ZGkwcUNrLThfc3l5c2FYVlZnTk9wbEUzQVdQUFhxRGdMYkxTX2FMOUVvQlE?oc=5","date":"2024-04-12","type":"pipeline","source":"Bloomberg.com","summary":"Nuclear Medicine Is Big Pharma’s New Target in Cancer Race - Bloomberg.com","headline":"Nuclear Medicine Is Big Pharma’s New Target in Cancer Race","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNcnpuTEVyRElmMjlwcll2QWdGVXlvdi1tOERraEJjWjM3Y3F4YkJnbUxnREZneGxpSUVBZHZWdjE2T1V2cnN3aDdyYjg4NzNubEZsZnRVbTRXQVVMYnlqNVVCMVNmU1QzT0JfdkJzaW9WRjRTOXl0VkIxeTRzWk9RR2hLenRCYXBjNmQwazZPWlIzdVBNQTlzOEZFa0Y1QUFkc3Bn?oc=5","date":"2024-03-09","type":"pipeline","source":"The Globe and Mail","summary":"B.C. biotech boom: Vancouver looks to join the global big leagues of modern medicine - The Globe and Mail","headline":"B.C. biotech boom: Vancouver looks to join the global big leagues of modern medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOaXk4cm90OWhXcXd3M1VRM2J5ZWtNTW1QbzNqOWpaRjJDS2hqNGpOMTZTWDdicG5tLUp0SFBubWc4YXlWVW9UZWNCSXFXNUo1Y3hqblVoaTNwVWNGTzlmbXQ4SGVXNGNaeTZsekRhSHVaanVra2JNSzdyM1B3WUZ4X3ZZVHlpRUVWWnpvUVBMMTQ1MXNVX3c?oc=5","date":"2023-04-20","type":"pipeline","source":"BioPharma Dive","summary":"Startup Abdera raises $110M to fuel radiopharmaceutical research - BioPharma Dive","headline":"Startup Abdera raises $110M to fuel radiopharmaceutical research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPMVFsNlhtcE5xUVlyRjJOcGxKNVBXLWNMdFpoNm03WUhkbnBjRFU5RmpmZ2E3NmVWeDh3MFdhN3ltWVpvUWxYOUhYbGdZRG8wMTYwNTZ2T2VSU256amozbEgyZzZGSy1oYzVEUE1rN3gteWs1d1lZWHBDT2g2Mnd4UTlwQnJRNDNkZjNn?oc=5","date":"2023-04-20","type":"pipeline","source":"The Globe and Mail","summary":"AbCellera-backed precision medicine startup Abdera raises $140-million to target tumors - The Globe and Mail","headline":"AbCellera-backed precision medicine startup Abdera raises $140-million to target tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxOUUdfUkpQUEFXYkF5VGhQb3I5alpoZmgyVXZVNmRBcUFiUHN5QzliZlJOYW9QaEd6b3dvTDZQQjk4TGhRTmFaYXNBLU1Ia0gyYXpOZWVtMF9SdjlHSi02UGlXMFN5N1pqcjl0T0VfYk5rQU9wcUNMYmpGR0FqRE1ycUxLTnF0REdobGxXZ1pVV3ZucDJTUW5HSklyWEkyMGVJRWhkLXlzM1BaZ3FLNy1pTzBjQmZsNXd0a2dNUF9pRnJOa3k3TEM3VDRlbGo3T2I2Z1hnbVRRVEY3Sk83MDBaRDF0SnhJcW9ySE96VEdkbDh5QUQwNjU1eGtoZFBNSnRDa0N5a0U0ZmxLQ1I4aU54ZFh0Q0IwWFp2RUlqTkRkdkM4bTlOT0JmRA?oc=5","date":"2023-04-20","type":"pipeline","source":"businesswire.com","summary":"Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer - businesswire.com","headline":"Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiophar","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}